A report has found that more than 57 million prescriptions for opioids such as tramadol, codeine and fentanyl, were issued to UK patients last year. The equivalent of one prescription every 108 minutes. The report, created by Sapphire Clinics, found that one in seven (14%) chronic [...]
Volteface and The Medical Cannabis Clinicians Society (MCCS) have today been appointed as the new secretariat for the UK’s medical cannabis All-Party Parliamentary Group (APPG). APPGs are informal cross-party groups that have no official status within Parliament, but seek to unite groups of MPs and peers [...]
Each week we bring you the latest news and regulatory developments in cannabis across Europe. The top lines this week: Luxembourg prepares to vote on proposals for an adult-use experiment; Israel introduces new regulations to make it easier for patients to access cannabis on prescriptions and [...]
Via Business of Cannabis The highly-anticipated regulation and roll out of legal access to medical cannabis in Spain, already over six months overdue, is now under threat of being set aside completely. After suffering heavy losses in local elections at the end of May, the Spanish Prime Minister [...]
New research supports the use of CBD for seizure reduction, nicotine withdrawal and sleep, while scientists shed more light on the impact of prenatal cannabis use. Researchers across the world are investigating the therapeutic potential of cannabis in managing a wide range of conditions. In recent [...]
The Medical Cannabis on Prescription APPG has appointed two industry organisations as its new secretariat, bringing a new ‘bold strategy and vision’ to instigate change. Volteface and The Medical Cannabis Clinicians Society (MCCS), announced on Wednesday 14 June, that the two have been elected as the [...]
A patient of Zerenia Clinics UK has made history as the first to secure NHS reimbursement for prescribed cannabis flowers. After a patient from Zerenia Clinics UK was reimbursed by the NHS for their therapy with cannabis-based oral extracts in January 2023, a second patient from [...]
Cannabis consumers in the US span a broad spectrum of demographics, but almost all are looking for a way to switch off, finds a new report. A new report examining the demographics of cannabis users in the US dispels some of the long-existing myths and stereotypes [...]
Jersey is to establish a new ‘cannabis agency’ to improve regulation of the medicinal cannabis sector and reduce the risk of prescriptions being resold on the illicit market. Officials in the Crown Dependency have addressed calls for further governance and regulation of the island’s medicinal cannabis [...]
In Part 1, we examined the current status of adult use cannabis in Minnesota, paying particular attention to the licensing framework, taxation and social equity considerations. In this article, we’ll cover some important need-to-know info if you’re considering opening an adult use business in the “Land [...]
This is the fourth in a series of articles designed to introduce an integrated pest management framework for cannabis cultivation facilities. To see Part One, an overview of the plan and pest identification, click here. For Part Two, on pest monitoring and record keeping, click here. [...]
Cannabis brands are facing a proverbial fork in the road: determining whether their product evolves into a luxury consumable or affordable agricultural commodity. While it is reasonable to assume the cannabis market space will organically grow into a luxury goods industry such as wine and spirits, [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
